Evidence map›Paper›PMID 40231034›Full record

ReviewCurrent journal of neurology2024

The effect of interferon beta on quality of life in patients with multiple sclerosis: A systematic review and meta-analysis study.

Mohammadreza Jamshidi, Milad Abbasian, Ali Ghasemnezhad, Atoosa Keshavarz-Motamed, Zehra Batool, Arian Tavasol, Mahsa Nikfarjam, Mohammad Moein Ashrafi, Atefeh Zare-Ahmadabadi, Seyyed Ali Jalalian

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammadreza JamshidiDepartment of Anesthesiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Milad AbbasianNargund College of Physiotherapy, Rajiv Gandhi University of Health Sciences, Bangalore, India.
Ali GhasemnezhadSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Atoosa Keshavarz-MotamedStudent Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Zehra BatoolDr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Arian TavasolStudent Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mahsa NikfarjamStudent Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Moein AshrafiSchool of Medicine, Yazd Branch, Islamic Azad University, Yazd, Iran.
Atefeh Zare-AhmadabadiSchool of Medicine, Yazd Branch, Islamic Azad University, Yazd, Iran.
Seyyed Ali JalalianSchool of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Interferon BetaMultiple SclerosisQuality of Life

Identifiers

PMID40231034
PMCPMC11994062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.